School of Medicine
Showing 51-100 of 1,039 Results
-
Laren Becker
Assistant Professor of Medicine (Gastroenterology)
BioI am a physician-scientist in the Division of Gastroenterology at Stanford University. My clinical and research interest has been in neurogastroenterology. Specifically, my research has been exploring the interplay between immune cells and the enteric nervous system, and evaluating how perturbations of this interaction as a result of aging disrupts gastrointestinal neuromuscular function. Ultimately, my hope is that insights from this research provide novel therapies for treating patients with motility disorders like constipation and irritable bowel syndrome.
-
Harmeet Bedi
Clinical Associate Professor, Medicine - Pulmonary, Allergy & Critical Care Medicine
BioDr. Harmeet Bedi is the Director of Interventional Pulmonology & Bronchoscopy at Stanford University. His expertise is in minimally invasive techniques used in the diagnosis and treatment of various airway and lung diseases such as lung cancer, benign & malignant airway obstruction, and pleural diseases. He specializes in rigid & flexible bronchoscopy, robotic bronchoscopy, airway stent placement, balloon bronchoplasty, endobronchial ultrasound (EBUS), and various pleural procedures. He also specializes in a variety of tumor ablative therapies including laser therapy, electrocautery, argon plasma coagulation (APC), brachytherapy, and cryotherapy.
He founded the cone-beam computed tomography (CBCT) - guided bronchoscopy program at Stanford in 2019. CBCT-guided bronchoscopy is a novel and cutting-edge technique which combines bronchoscopy with CT imaging, allowing for improved localization and diagnosis of peripheral lung nodules. Additionally, CBCT-guided bronchoscopy will allow for numerous potential cancer therapies that are currently under development.
Dr. Bedi is a principal investigator and co-investigator on multiple clinical trials related to bronchoscopy, thoracic imaging, pulmonary nodules, and lung cancer. Specifically, he has multiple research interests within the realm of bronchoscopic device innovation and CBCT-guided bronchoscopy. -
Eran Bendavid
Associate Professor of Medicine (Primary Care and Population Health), of Health Policy, Senior Fellow at the Woods Institute for the Environment and, by courtesy, at the Freeman Spogli Institute for International Studies
Current Research and Scholarly InterestsEffect of global health policies on health of individuals in developing countries, global health, HIV and TB.
-
Allison Betof Warner, MD, PhD
Assistant Professor of Medicine (Oncology)
BioDr. Betof Warner is a board-certified, fellowship-trained medical oncologist with the Cutaneous Oncology Program and an Assistant Professor in the Department of Medicine, Division of Medical Oncology. She also serves as Director of Melanoma Medical Oncology, Director of Solid Tumor Cellular Therapy, and co-Director of the Pigmented Lesion and Melanoma Program.
Clinical interests of Dr. Betof Warner include treatment of advanced melanoma, immunotherapy, and cellular therapies for solid tumors. She has been a pioneer in the use of commercial tumor infiltrating lymphocyte (TIL) therapy, which is expected to become standard of care for immunotherapy-refractory melanoma.
Dr. Betof Warner serves as the leader of the Melanoma & Cutaneous Oncology Clinical Research Group, with research interests focused on tumor response to immunotherapy. She has been the principal investigator of multiple clinical trials focusing on immunotherapy-refractory melanoma and is internationally recognized for her expertise in central nervous system metastases and the use of novel cellular therapies. Dr. Betof Warner collaborates with investigators around the world in surgery, neuro-oncology, neurosurgery, radiation oncology, and pathology. She has received funding and awards for her clinical and translational investigative work from multiple high-profile organizations, including the American Society of Clinical Oncology (ASCO), National Institutes of Health (NIH), and Melanoma Research Foundation.
In addition to publishing her research in peer-reviewed journals, Dr. Betof Warner has served as an editorial and grant reviewer for multiple organizations, including the Melanoma Research Foundation. She has authored book chapters and case reports, contributed to national guidelines, and presented her findings at regional, national, and international meetings.
Dr. Betof Warner is a member of multiple professional organizations and societies, including the American Association for Cancer Research, the American Society of Clinical Oncology, and the Society for Immunotherapy of Cancer, where she serves on the Early Career Scientist Committee. She is also a member of the American College of Sports Medicine and the European Society for Medical Oncology. -
Vivek Bhalla, MD
Associate Professor of Medicine (Nephrology)
On Partial Leave from 03/01/2024 To 08/31/2024Current Research and Scholarly InterestsDr. Bhalla's two primary research interests are in the role of the kidney in diabetes and hypertension. We use molecular, biochemical, and transgenic approaches to study: (1) mechanisms diabetic kidney disease disease including the role of the endothelium to regulate inflammation and kidney injury; and (2) regulation of tubular transport of glucose, sodium, and potassium. These latter studies have treatment implications in diabetes, kidney disease, and hypertension.
-
Sushma Bharadwaj, MD
Instructor, Medicine - Blood & Marrow Transplantation
BioDr. Bharadwaj is fellowship-trained in blood and marrow transplantation, cellular therapy, hematology, and oncology. She is an instructor in the Stanford School of Medicine Department of Medicine, Division of Blood & Marrow Transplantation and Cellular Therapy.
Dr. Bharadwaj focuses her expertise on diagnosing and treating cancer in blood and bone marrow. For each patient, she develops a personalized, comprehensive, and compassionate care plan. In her diverse experience as a physician and scientist, she has served as an internal medicine doctor, hospitalist, hematologist, oncologist, and blood and marrow transplantation specialist. Dr. Bharadwaj has a degree in clinical research and is currently conducting clinical trials in transplant and cellular therapy.
She has participated in research studies of advances in therapy for chronic lymphocytic leukemia, melanoma, and breast cancer. She has co-authored articles published in Leukemia and Lymphoma and elsewhere. Topics include advances in cell transplantation. She also co-wrote the chapter on genome-driven personalized cancer therapy in the book Precision Medicine in Oncology.
Dr. Bharadwaj has made presentations at meetings of the American Society of Hematology, American Society of Clinical Oncology, and other associations.
Subjects include racial, demographic, and socioeconomic disparities in the treatment of patients with acute myeloid leukemia.
Dr. Bharadwaj is a member of the American Society for Transplantation and Cellular Therapy, American Society of Hematology, and American Society of Clinical Oncology. -
Ami Bhatt
Associate Professor of Medicine (Hematology) and of Genetics
Current Research and Scholarly InterestsThe Bhatt lab is exploring how the microbiota is intertwined with states of health and disease. We apply the most modern genetic tools in an effort to deconvolute the mechanism of human diseases.
-
Brian Blackburn
Clinical Professor, Medicine - Infectious Diseases
Current Research and Scholarly InterestsMy interests include parasitology and global health; I've investigated cryptosporidium and angiostrongylus outbreaks; schistosoma/strongyloides seroprevalence in refugees, and the distribution and impact of ITNs for malaria and filariasis prevention in Nigeria and India. I have done clinical and programmatic work at teaching hospitals in Liberia and Bangladesh and have opportunities for research in Bangladesh and Kenya, in collaboration with ICDDR,B and CDC, Kenya
-
Terrence Blaschke
Professor of Medicine and of Molecular Pharmacology, Emeritus
Current Research and Scholarly InterestsClinical pharmacology of antiretroviral drugs
Pharmacokinetic and pharmacodynamic mechanisms of variability in drug response.
Drug development -
Douglas W. Blayney
Professor of Medicine (Oncology), Emeritus
Current Research and Scholarly InterestsImproving the quality of cancer care at Stanford, in our network of care, and nationally
-
Catherine Blish
George E. and Lucy Becker Professor in Medicine
Current Research and Scholarly InterestsThe major goal of our research is to gain insight into the prevention and control of HIV and other viral pathogens by studying the interplay between the virus and the host immune response. We investigate the role of various arms of the immune response, but with a particular focus on NK cells. We hope to gain additional insights into control of infectious diseases by studying how pregnancy modulates immune responses.
-
Gordon Bloom
Lecturer, Medicine - Primary Care and Population Health
BioGordon founded the Social Entrepreneurship Collaboratory (SE Labs) at Stanford, Harvard and Princeton. He teaches about the design, development and leadership of innovative social impact ventures in global health and environmental sustainability.
At Stanford, Gordon is director of the Social Entrepreneurship and Innovation Lab (SE Lab)- Human & Planetary Health and is a faculty fellow of the Center for Innovation in Global Health. He is a Lecturer in the School of Medicine, Division of Primary Care and Population Health/Dept. of Medicine, and an advisor in the Distinguished Careers Institute (DCI), and the Knight-Hennessy Scholars Program, and cofounder of the Stanford Sustainable Societies Lab.
At Harvard, Gordon taught jointly on the faculties of the Harvard T. H. Chan School of Public Health (Health Policy & Management) and the Harvard Kennedy School (Management, Leadership & Decision Sciences) and served as an Expert-in-Residence (EiR) at the Harvard Innovation Lab (i-Lab), and affiliated faculty at the Center for Primary Care, Harvard Medical School (HMS). He was faculty director of the Social Entrepreneurship and Innovation Lab (SE Lab) for US & Global Health, an incubator course taught in a new interdisciplinary, collaborative model based at the i-Lab. He has also served as an Entrepreneur-in-Residence (2013-2014) at Harvard Business School in the Rock Center for Entrepreneurship, on the Faculty of Arts & Sciences in the Sociology Department, at the Harvard Kennedy School, on the Leadership & Management faculty, and as a principal of the Hauser Center for Non-Profit Organizations (2004-2007). Gordon served as one of the founding faculty of the $10 million Reynolds Fellows Program in Social Entrepreneurship, a Center for Public Leadership and Harvard President’s interdisciplinary fellowship initiative that paid full tuition and stipend for graduate students from the Harvard Kennedy School, School of Public Health and Graduate School of Education.
At Princeton, Gordon served as Dean’s Visiting Professor in Entrepreneurship in 2009-2010. Working together with the School of Engineering & Applied Science, the [Woodrow Wilson] School of Public & International Affairs, and the Faculty of Arts & Sciences, he launched a new set of programs and prizes in social innovation and entrepreneurship in collaboration with students, faculty and alumni.
At Stanford in 2001-2002, Gordon created the SE Lab, a Silicon Valley and technology–influenced, interdisciplinary incubator for social impact ventures and global problem solving. Gordon taught on the Public Policy Program and Urban Studies Program faculties (School of Humanities & Sciences) and served as a faculty affiliate at the Center for Social Innovation at Stanford Graduate School of Business, and a Program Officer at Stanford’s Freeman Spogli Institute for International Studies.
Many of the talented students and fellows in Gordon’s SE Labs have won the top awards of prestigious idea and business plan competitions, including those at Stanford, Harvard, Princeton and MIT.
Gordon is a co-author in the edited volume Frontiers in Social Innovation (N. Malhotra, ed., Harvard Business Review Press, 2022) and Social Entrepreneurship: New Models of Sustainable Social Change (A. Nicholls, ed., Oxford University Press, 2006/2008) and served as a founding member of the Oxford/Ashoka led University Network for Social Entrepreneurship. His interest in entrepreneurship is informed by work in both the private and nonprofit sectors in the U.S. (New York, Cambridge, Palo Alto), Europe (London, Paris) and Asia (Hong Kong), as CEO of a medical technology company (EDAP Technomed, USA) and in international strategy consulting (Bain & Co. Ltd.).
Gordon is married to Sara Singer- they on occasion teach together at Stanford, have a daughter Audrey and son Jason, and live in the Frenchman's Hill residential section of campus. -
Bryan Bohman
Clinical Professor, Medicine - Primary Care and Population Health
BioBryan Bohman is Associate Chief Medical Officer for Workforce Health and Wellness. Additional roles include Clinical Professor of Medicine and of Anesthesiology, Co-Director of the Clinical Effectiveness Leadership Training (CELT) program and Senior Advisor to the WellMD Center.
Bryan trained at Stanford in internal medicine and anesthesiology. After two decades of clinical practice in community-based anesthesiology, he served as SHC's first elected Chief of Staff from 2008-2011.
As Chief of Staff, Dr. Bohman established Stanford’s wellness committee and subsequently shepherded the founding of its WellMD Center in 2015, serving as the Center’s interim Director until 2017. The Center’s aim is to advance faculty, trainee and care team wellbeing across Stanford Medicine while also serving as an international leader of scholarship in occupational wellbeing. Bryan also led the establishment in 2014 of the CELT program, which continues to serve as a driver of clinical quality improvement across Stanford Medicine.
Dr. Bohman’s primary areas of interest include occupational wellbeing, process improvement, and the reciprocal influences between quality improvement, healthcare system performance, and the occupational wellbeing of healthcare personnel. -
Paul Bollyky
Associate Professor of Medicine (Infectious Diseases) and of Microbiology and Immunology
Current Research and Scholarly InterestsChronic bacterial infections are a major health care problem. Our lab is interested in understanding the host and microbial factors that perpetuate chronic infections and in developing novel therapeutic interventions to improve human health.
-
Hector Fabio Bonilla
Clinical Associate Professor, Medicine - Infectious Diseases
BioAs a young physician at Louisiana State University, Dr. Bonilla focused on the Clinical Management of HIV/AIDS and HCV, two neglected and stigmatized diseases for which effective therapies were in their infancy. While learning the clinical aspects of the two diseases, Dr. Bonilla saw a need to create and organize a support community to promote understanding and management of the conditions. Subsequently, he went to Summa Health System in Akron, Ohio, and he continued his work where he specialized in HIV/HCV as well as in Infectious Diseases Clinical Practice. In addition to teaching medical residents and students, Dr. Bonilla participated in numerous clinical trials and developed clinical research projects. Furthermore, he led the Infection Renal Transplant Program, HIV and HCV clinics, and he participated in several cooperative studies with Case Western Reserve University. Dr. Bonilla’s interest in academia led him to the University Of Pittsburgh Medical Center where he was an Assistant Professor, Clinician, and Medical Educator in the Department of Medicine in the Division of Infectious Diseases. Due to his interest in cytokines and immunological responses, Dr. Bonilla became a researcher at ImmunoScience Inc., a biotechnology company in California that works to develop a therapeutic HIV vaccine. Dr. Bonilla’s experience of treating HIV/HCV combined with his interest in inflammatory response is the driving force behind his desire to understand ME/CFS. Dr. Bonilla is a strong patient advocate, and he believes in integrated care—care in which physicians communicate and coordinate efforts to deliver the best medical outcome for patients. His ME/CFS patients are his inspiration, and he is committed to continuing research to seek answers to their health challenges.
-
Linda Boxer, MD, PhD
Vice Dean of the School of Medicine and Stanley McCormick Memorial Professor
Current Research and Scholarly InterestsRegulation of expression of oncogenes in normal and malignant hematologic cells.
-
Heather E Boynton
Adjunct Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioHeather E Boynton is an emergency physician at Pioneers Memorial Hospital in Brawley, California and an Adjunct Clinical Assistant Professor at the Stanford University School of Medicine in the Department of Primary Care and Population Health.
Dr. Boynton trained in emergency medicine at UC San Diego, where she served as chief resident. She attended medical school at Georgetown University and also has a master’s degree in International Security Studies from the School of Foreign Service. She completed her undergraduate studies at Princeton University.
As an emergency physician practicing in a rural, cross-border community she hopes to challenge and engage rotating students to provide patient-centered care in a resource-limited setting. -
Brian Brady
Clinical Associate Professor, Medicine - Nephrology
BioDr. Brady is a fellowship-trained nephrologist with board certification in nephrology and in internal medicine. He is a clinical assistant professor in the Department of Medicine, Division of Nephrology, at Stanford University School of Medicine.
He provides care at the Stanford Health Care Boswell Kidney Clinic as well as the Stanford Health Care Kidney Clinic in Emeryville.
Dr. Brady is particularly interested in the management of patients with chronic kidney disease (CKD). He also treats end-stage kidney disease, hypertension, kidney stones, glomerular disease and other kidney related conditions.
His research in value-based health care focuses on methods to improve care delivery for patients with CKD and end-stage kidney disease (ESKD). He has received funding for his research from sources including the National Institutes of Health.
Dr. Brady has published his research findings in JAMA Internal Medicine the Journal of the American Society of Nephrology, and elsewhere.
He has presented invited talks on high-value care delivery to policy makers on Capitol Hill in Washington, DC. He also has made presentations to his peers at national, regional, and local meetings of kidney disease specialists.
He has delivered lectures to the Institute for Healthcare Improvement National Forum, Satellite Healthcare Home Dialysis Academy, and other meetings. He has shared his insights in presentations to faculty and students in the Division of Nephrology at Peking Union Medical College in Beijing, China.
Dr. Brady is a member of the American Society of Nephrology, International Society of Nephrology, and American College of Physicians. -
Rondeep Brar
Clinical Associate Professor, Medicine - Hematology
BioAs the Medical Director of the Stanford Cancer Center and Associate Director for Clinical Care at the Stanford Cancer Institute, it is my privilege to partner with my colleagues in advancing innovative research alongside high quality, coordinated, and compassionate care.
I aim to provide high quality care in a diverse patient practice. My clinic includes all types of hematologic disorders, ranging from anemia, clotting/bleeding disorders, and low blood counts to complex malignancies such as leukemia, myelodysplastic syndrome, myeloma, and lymphoma. I aim to combine the efficiency of a private office with the complex care expected of a tertiary institution like Stanford. I value your time and strive to maintain an on-schedule clinic. -
Michelle Elizabeth Yael Braunschweig, MD, PhD, MPH
Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioDr. Braunschweig is a board-certified family medicine doctor. She provides care for the entire family and welcomes patients of all ages.
Her special interests include women’s health, children’s health, and mental health. For each patient, she develops a personalized plan of care. Her goal is to help every individual achieve the best possible health and quality of life.
Another special interest of Dr. Braunschweig is medical education. She is a Clinical Assistant Professor in the Department of Medicine, Division of Primary Care and Population Health, at Stanford University School of Medicine.
The training of health care professionals in low-resource settings is one of her key research interests. Another is reproductive justice.
Dr. Braunschweig grew up in San Jose. Prior to medical school, Dr. Braunschweig studied music and earned a PhD in musicology from UC Berkeley. Her interest in women’s health led her to volunteer as a birth doula at San Francisco General Hospital.
There, she became passionate about maternal and child health, and was inspired to go to medical school to become a doctor.
Outside of her clinical practice and research, she enjoys spending time with her family, going for walks, and trying out new recipes. -
Keri Brenner
Clinical Associate Professor, Medicine - Primary Care and Population Health
BioKeri Brenner, MD, MPA is Clinical Associate Professor of Medicine at Stanford University. As a palliative care physician and psychiatrist, her clinical work includes inpatient palliative care consultations at Stanford. She was inspired to pursue palliative care after serving at Mother Teresa’s Home for the Dying in Kolkata, India on multiple occasions. Dr. Brenner’s scholarly interests and research focus on the psychological elements of palliative care, specifically psychodynamic and existential issues in patients with serious illness. Dr. Brenner completed her medical degree at Yale School of Medicine, where she received honors for her thesis on the phenomenology of suffering with terminal illness. She also has a Master in Public Administration from Harvard’s Kennedy School. Dr. Brenner completed adult psychiatry residency at Massachusetts General Hospital and palliative care fellowship at Harvard. She served on the University of Notre Dame Board of Trustees (2005-2008), and was awarded funding through Harvard’s Radcliffe Institute for Advanced Study (2019). In her personal life, Dr. Brenner enjoys the beautiful outdoors of Northern California with her husband and four young children.
-
Nam Quoc Bui
Clinical Assistant Professor, Medicine - Oncology
BioDr. Bui is a Clinical Assistant Professor of Medicine at the Stanford Cancer Institute and a specialist in Sarcoma. Dr. Bui earned an undergraduate degree in Computer Science at Stanford University and went on to earn his medical degree from the University of Texas Southwestern Medical Center. He completed Internal Medicine residency at Stanford Hospital and Hematology/Oncology fellowship at the University of California San Diego, where he performed extensive research in bioinformatics to analyze tumor sequencing data.
His research background and interests are in the field of bioinformatics as applied to large data sets and the study of novel compounds in rare malignancies. He is involved in numerous sarcoma clinical trials, leading efforts to take new therapeutics from the lab to clinical practice. He also is involved in education at the Stanford University School of Medicine, serving as a lecturer and mentor to students and trainees. Dr. Bui is the founding Editor-in-Chief of the journal “Current Problems in Cancer: Case Reports”, an international, peer-reviewed journal that publishes groundbreaking cases that give insight into redefining concepts in cancer. -
Alison Callahan
Instructor, Medicine - Biomedical Informatics Research
BioAlison Callahan is an Instructor in the Center for Biomedical Informatics and Clinical Data Scientist in the Stanford Health Care Data Science team led by Nigam Shah. Her current research uses informatics to expand and improve the data available about pregnancy and birth, and to develop and maintain and EHR-derived obstetric database. She is also the co-leader of the OHDSI Perinatal & Reproductive Health (PRHeG) working group. Her work in the SHC Data Science team focuses on developing and implementing methods to assess and identify high value applications of machine learning in healthcare settings.
Alison completed her PhD in the Department of Biology at Carleton University in Ottawa, Canada. Her doctoral research focused on developing HyQue, a framework for representing and evaluating scientific hypotheses, and applying this framework to discover genes related to aging. She was also a developer for Bio2RDF, an open-source project to build and provide the largest network of Linked Data for the life sciences. Her postdoctoral work at Stanford applied methodologies developed during her PhD to study spinal cord injury in model organisms and humans in a collaboration with scientists at the University of Miami. -
Michelle Thi Cao
Clinical Professor, Medicine - Pulmonary, Allergy & Critical Care Medicine
Current Research and Scholarly InterestsPositive Airway Pressure devices for central sleep apnea
-
Robert W. Carlson
Professor of Medicine (Oncology and General Internal Medicine/Medical Informatics) at the Stanford University Medical Center, Emeritus
Current Research and Scholarly InterestsClinical investigations in breast cancer include institutional and NSABP studies of chemoprevention, adjuvant therapy, psychosocial interventions, treatment of metastatic disease, methods of decreasing anthracycline cardiotoxicity, and modulation of multidrug resistance. Research in meta-analysis includes the performance of meta-analysis in a wide variety of settings in cancer treatment by the international Meta-Analysis Group in Cancer.
-
Chris Cartwright, MD
Professor of Medicine (Gastroenterology and Hepatology), Emerita
Current Research and Scholarly InterestsMolecular mechanisms of intestinal cell growth control; function and regulation of the Src family of tyrosine kinases in normal cells, and their deregulation in cancer cells.
-
Jennifer Caswell-Jin
Assistant Professor of Medicine (Oncology)
Current Research and Scholarly InterestsMy research is on the translational application of next-generation sequencing technologies to breast cancer care: (1) the value of hereditary cancer genetic panel testing in clinical practice, (2) the mechanisms by which inherited genetic variants lead to breast cancer development, and (3) the analysis of somatic tumor sequencing data to inform understanding of breast tumorigenesis, metastasis, and development of resistance in response to therapeutics.
-
Yashaar Chaichian, MD
Clinical Associate Professor, Medicine - Immunology & Rheumatology
Current Research and Scholarly InterestsSystemic lupus erythematosus
CTD-associated interstitial lung disease
